J Gynecol Oncol > v.24(2)

15 results

103 LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
Mi Kyoung Kim, Seok Ju Seong
KMSID: 1079040   J Gynecol Oncol. 2013;24(2):103-104.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.103
         
105 Should studies of maintenance therapy be maintained in women with ovarian cancer?
Michael A. Bookman
KMSID: 1079041   J Gynecol Oncol. 2013;24(2):105-107.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.105
         
108 Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
Kimio Ushijima, Keizo Fujiyoshi, Kouichiro Kawano, Naotake Tsuda, Shin Nishio, Hidehiro Eto, Toshiharu Kamura
KMSID: 1079042   J Gynecol Oncol. 2013;24(2):108-113.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.108
         
114 Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?
Ibrahim Kulac, Alp Usubutun
KMSID: 1079043   J Gynecol Oncol. 2013;24(2):114-119.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.114
         
120 A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
Ha-Jeong Kim, Tae-Joong Kim, Yoo-Young Lee, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
KMSID: 1079044   J Gynecol Oncol. 2013;24(2):120-127.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.120
         
128 LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
Hatem Abu Hashim, Abdelhady Zayed, Essam Ghayaty, Mohamed El Rakhawy
KMSID: 1079045   J Gynecol Oncol. 2013;24(2):128-134.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.128
         
135 Reproductive factors for ovarian cancer in southern Chinese women
Maria Pasalich, Dada Su, Colin W. Binns, Andy H. Lee
KMSID: 1079046   J Gynecol Oncol. 2013;24(2):135-140.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.135
         
141 CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
Naoto Furukawa, Yoshikazu Sasaki, Aiko Shigemitsu, Juria Akasaka, Seiji Kanayama, Ryuji Kawaguchi, Hiroshi Kobayashi
KMSID: 1079048   J Gynecol Oncol. 2013;24(2):141-145.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.141
         
146 Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
Jee Suk Chang, Woong Sub Koom, Sang Wun Kim, Sunghoon Kim, Yong Bae Kim, Young Tae Kim, Gwi Eon Kim
KMSID: 1079049   J Gynecol Oncol. 2013;24(2):146-153.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.146
         
154 A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer
Seiji Isonishi, Masaaki Suzuki, Hiroaki Nagano, Koichiro Takagi, Masahito Shimauchi, Masakiyo Kawabata, Kazuhiko Ochiai
KMSID: 1079050   J Gynecol Oncol. 2013;24(2):154-159.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.154
         
160 Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study
Emine Karabuk, M. Faruk Kose, Deniz Hizli, Salih Taşkin, Burak Karadağ, Taner Turan, Nurettin Boran, Ahmet Ozfuttu, U. Fırat Ortaç
KMSID: 1079051   J Gynecol Oncol. 2013;24(2):160-166.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.160
         
167 Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status
Luis Felipe Sallum, Luis Otavio Sarian, Liliana Lucci De Angelo Andrade, José Vassallo, Fernando Augusto Soares, Glauce Aparecida Pinto, Patrícia Andréia Ferreira, Sophie Derchain
KMSID: 1079052   J Gynecol Oncol. 2013;24(2):167-176.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.167
         
177 The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats
Xiaohuan Li, Shu Yang, Xiangyang Lv, Haimei Sun, Jing Weng, Yuanjing Liang, Deshan Zhou
KMSID: 1079053   J Gynecol Oncol. 2013;24(2):177-185.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.177
         
186 Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
Jae Kwan Lee, Jin Hwa Hong, Sokbom Kang, Dae-Yeon Kim, Byoung-Gie Kim, Sung-Hoon Kim, Yong-Man Kim, Jae-Weon Kim, Jae-Hoon Kim, Tae-Jin Kim, Hyun Jung Kim, Hye Sun Kim, Hee-Sug Ryu, Jae Yun Song, Hyeong Sik Ahn, Chong Woo Yoo, Hye-Kyoung Yoon, Keun-Ho Lee, Ahwon Lee, Yonghee Lee, In Ho Lee, Jeong-Won Lee, Taek Sang Lee, Myong Cheol Lim, Suk-Joon Chang, Hyun Hoon Chung, Woong Ju, Hee Jae Joo, Soo-Young Hur, Sung-Ran Hong, Joo-Hyun Nam
KMSID: 1079054   J Gynecol Oncol. 2013;24(2):186-203.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.186
         
204 Maintenance of ovarian function in end-of-life cervical cancer patient following primary surgico-radiotherapy and ovarian transposition
Renee Vina G. Sicam, Kuan-Gen Huang, Yung-Chia Chang, Chyi-Long Lee
KMSID: 1079055   J Gynecol Oncol. 2013;24(2):204-207.   Published online 2013 April 5    DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.204
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology